Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-11 4:01 pm Purchase | 2025-02-06 | 13G | UWM Holdings Corporation UWMC | Integrated Core Strategies (US) LLC | 10,558,347 6.700% | 10,245,670![]() (+3276.76%) | Filing History |
2025-02-11 4:00 pm Purchase | 2025-02-05 | 13G | Cumberland Pharmaceuticals Inc. CPIX | Integrated Core Strategies (US) LLC | 1,229,633 8.800% | 1,229,633![]() (New Position) | Filing History |
2025-02-10 4:08 pm Sale | 2024-12-31 | 13G | Acelyrin, Inc. SLRN | Integrated Core Strategies (US) LLC | 4,714,402 4.700% | -431,027![]() (-8.38%) | Filing History |
2025-02-06 4:07 pm Sale | 2024-12-31 | 13G | COMPASS Pathways plc CMPS | Integrated Core Strategies (US) LLC | 3,413,448 3.700% | -473,753![]() (-12.19%) | Filing History |
2025-01-30 4:00 pm Sale | 2024-12-31 | 13G | Accolade, Inc. ACCD | Integrated Core Strategies (US) LLC | 3,090,861 3.800% | -999,481![]() (-24.44%) | Filing History |
2025-01-28 4:00 pm Sale | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Integrated Core Strategies (US) LLC | 1,994,503 3.500% | -954,373![]() (-32.36%) | Filing History |
2025-01-27 4:00 pm Sale | 2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | Integrated Core Strategies (US) LLC | 6,292,634 4.300% | -3,107,939![]() (-33.06%) | Filing History |
2025-01-22 4:01 pm Purchase | 2025-01-14 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Integrated Core Strategies (US) LLC | 1,382,273 6.500% | 1,382,273![]() (New Position) | Filing History |
2024-12-16 4:04 pm Purchase | 2024-12-09 | 13G | Pyxis Oncology, Inc. PYXS | Integrated Core Strategies (US) LLC | 3,160,139 5.300% | 3,160,139![]() (New Position) | Filing History |
2024-11-13 4:28 pm Sale | 2024-09-30 | 13G | Plum Acquisition Corp. III PLMJ | Integrated Core Strategies (US) LLC | 0 0.000% | -1,324,566![]() (Position Closed) | Filing History |
2024-11-12 4:19 pm Sale | 2024-09-30 | 13G | Vapotherm, Inc. VAPO | Integrated Core Strategies (US) LLC | 0 0.000% | -490,044![]() (Position Closed) | Filing History |
2024-11-12 4:15 pm Sale | 2024-11-07 | 13G | Avid Bioservices, Inc. CDMO | Integrated Core Strategies (US) LLC | 880,968 1.400% | -3,359,179![]() (-79.22%) | Filing History |
2024-11-07 4:25 pm Sale | 2024-09-30 | 13G | NETSTREIT Corp. NTST | Integrated Core Strategies (US) LLC | 3,825,273 4.700% | -78,168![]() (-2.00%) | Filing History |
2024-11-07 4:21 pm Sale | 2024-09-30 | 13G | Embecta Corp. EMBC | Integrated Core Strategies (US) LLC | 2,444,823 4.200% | -1,191,125![]() (-32.76%) | Filing History |
2024-11-06 4:08 pm Purchase | 2024-10-31 | 13G | PHINIA Inc. PHIN | Integrated Core Strategies (US) LLC | 2,272,842 5.400% | 2,272,842![]() (New Position) | Filing History |
2024-11-05 4:15 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Integrated Core Strategies (US) LLC | 1,628,534 1.900% | -1,851,096![]() (-53.20%) | Filing History |
2024-11-05 4:11 pm Sale | 2024-09-30 | 13G | Utz Brands, Inc. UTZ | Integrated Core Strategies (US) LLC | 2,805,867 3.400% | -1,383,200![]() (-33.02%) | Filing History |
2024-11-04 4:07 pm Sale | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | Integrated Core Strategies (US) LLC | 2,031,745 2.500% | -1,420,080![]() (-41.14%) | Filing History |
2024-11-01 4:05 pm Purchase | 2024-10-28 | 13G | Astria Therapeutics, Inc. ATXS | Integrated Core Strategies (US) LLC | 2,948,876 5.200% | 2,948,876![]() (New Position) | Filing History |
2024-10-31 4:23 pm Sale | 2024-09-30 | 13G | MaxCyte, Inc. MXCT | Integrated Core Strategies (US) LLC | 4,192,865 4.000% | -1,556,150![]() (-27.07%) | Filing History |